发明名称 Macrocyclic indole derivatives useful as hepatitis C virus inhibitors
摘要 Inhibitors of HCV replication of formula (I); including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R1, R2, R4, R5, R6 and R7 have the meaning defined in the claims. ;The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.
申请公布号 US9427440(B2) 申请公布日期 2016.08.30
申请号 US201313836168 申请日期 2013.03.15
申请人 Janssen Sciences Ireland UC 发明人 Vendeville Sandrine Marie Helene;Raboisson Pierre Jean-Marie Bernard;Lin Tse-I;Tahri Abdellah;Amssoms Katie Ingrid Eduard
分类号 A61K31/55;C07D513/14;C07D513/18;C07D515/18;A61K45/06;C07D513/22 主分类号 A61K31/55
代理机构 代理人 Kamage Andrea Jo
主权项 1. A method for inhibiting HCV replication, comprising administering to a subject in need thereof a compound of Formula (I) or a stereochemically isomeric form, N-oxide, salt, hydrate, or solvate thereof, wherein: R1 is a bivalent chain selected from each R3 is independently selected from the group comprising hydrogen, C1-4alkyl and C3-5cycloalkyl;a is 3, 4, 5 or 6;each b is independently 1 or 2;c is 1 or 2;macrocycle A has 14 to 18 member atoms;each R2 is independently hydrogen, halo or C1-4alkoxy;R4 and R5 are hydrogen or R4 and R5 together form a double bond or a methylene group to form a fused cyclopropyl;R6 is hydrogen or methyl; andR7 is a C3-7cycloalkyl optionally substituted with halo.
地址 Little Island, County Cork IE